0001261380-15-000011.txt : 20150114 0001261380-15-000011.hdr.sgml : 20150114 20150114204012 ACCESSION NUMBER: 0001261380-15-000011 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150109 FILED AS OF DATE: 20150114 DATE AS OF CHANGE: 20150114 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IRIDEX CORP CENTRAL INDEX KEY: 0001006045 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 770210467 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 BUSINESS ADDRESS: STREET 1: 1212 TERRA BELLA AVE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 6509404700 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mackaness James H CENTRAL INDEX KEY: 0001422484 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-27598 FILM NUMBER: 15528241 MAIL ADDRESS: STREET 1: 1212 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4/A 1 edgar.xml PRIMARY DOCUMENT X0306 4/A 2015-01-09 2015-01-09 0001006045 IRIDEX CORP IRIX 0001422484 Mackaness James H 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043 0 1 0 0 CFO and COO Common Stock 2015-01-09 4 A 0 40000 0 A 42000 D Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSU award shall vest as follows: (i) 20% of the RSUs will vest upon the grant date, and an additional 20% of the RSUs will vest upon each of the first, second, third and fourth anniversary of the grant date, (ii) an additional 10,000 of the RSUs will vest 60 days following the fourth anniversary of the grant date if the average closing price of the Issuer's Common Stock during the prior 60 day period equals or exceeds 100% of his target average closing price and (iii) an additional 20,000 of the RSUs will vest 60 days following the fourth anniversary of the grant date if the average closing price of the Issuer's Common Stock during the prior 60 day period equals or exceeds 120% of his target average closing price. /s/ Susan Bruce, Attorney-in-Fact for James H. Mackaness 2015-01-14